Skip to main content
. 2021 Mar 17;134(10):1160–1167. doi: 10.1097/CM9.0000000000001418

Table 2.

Correlations between HBcrAg and HBV DNA, HBsAg, anti-HBc, HAI score, and Ishak fibrosis score at baseline and 78 weeks after ETV therapy.

HBcrAg
HBeAg-positive HBeAg-negative
Baseline 78-week Baseline 78-week
Variables r P r P r P r P
HBV DNA 0.641 <0.001 −0.001 0.992 0.616 <0.001 −0.071 0.630
HBsAg 0.495 <0.001 0.164 0.116 0.221 0.115 0.208 0.151
Anti-HBc −0.102 0.343 −0.263 0.014 0.050 0.614 −0.291 0.045
HAI 0.232 0.025 0.035 0.739 0.118 0.405 −0.157 0.283
F −0.292 0.005 0.039 0.709 0.115 0.417 0.180 0.216

Anti-HBc: Anti-hepatitis B virus core antibody; F: Ishak fibrosis score; HAI: Histological activity index; HBcrAg: Hepatitis B core-related antigen; HBeAg: Hepatitis B e antigen; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.